Article: Gold(III) porphyrin 1a prolongs the survival of melanoma-bearing mice and inhibits angiogenesis

File Download Links for fulltext
(May Require Subscription)
Supplementary

  • Basic View
  • Metadata View
  • XML View
TitleGold(III) porphyrin 1a prolongs the survival of melanoma-bearing mice and inhibits angiogenesis
AuthorsLum, CT1
Huo, L1
Sun, RWY1
Li, M1
Kung, HF2
Che, CM1
Lin, MCM1 2
Issue Date2011
PublisherInforma Healthcare. The Journal's web site is located at http://www.tandf.co.uk/journals/titles/0284186x.asp
CitationActa Oncologica, 2011, v. 50 n. 5, p. 719-726 [How to Cite?]
DOI: http://dx.doi.org/10.3109/0284186X.2010.537693
AbstractBackground. Gold(III) meso-tetraphenylporphyrin (gold-1a) has previously been shown to prolong the survival of hepatocellular carcinoma (HCC)-bearing rats and nasopharyngeal carcinoma (NPC) metastasis-bearing mice. It has also been proved to inhibit the tumor growth of mice bearing NPC, neuroblastoma and colon carcinoma. Mechanistically, gold-1a induces apoptosis, inhibits cell migration and invasion. In this study the efficacies of gold-1a in inhibiting melanoma and angiogenesis were investigated. Material and methods. A mouse melanoma model was used to investigate the efficacy of gold-1a in inhibiting angiogenesis, tumor growth and prolonging the survival of the tumor-bearing animals. The model was established by inoculation of 2 × - 10 5 B16-F1 mouse melanoma cells into the right back flanks of the mice by subcutaneous inoculation. When the tumors grew to 0.2-0.4 cm in diameters, the mice were treated with gold-1a, solvent control or dacarbazine (DTIC) for comparison. Tumor sizes and animal survivals were monitored throughout the experiment. Tumor tissues were collected and immunohistochemically stained with CD31 antibodies for evaluation of intra-tumoral microvessel density (iMVD). Results and conclusion. Gold-1a significantly prolonged the survivals, reduced angiogenesis and tumor growth rates of melanoma-bearing mice. The compound induced necrosis and apoptosis in the mouse melanoma tissues. Gold-1a also downregulated the expression of genes playing roles in angiogenesis. Gold-1a may potentially be used to treat melanoma in patients. © 2011 Informa Healthcare.
ISSN0284-186X
2011 Impact Factor: 3.33
2011 SCImago Journal Rankings: 0.318
DOIhttp://dx.doi.org/10.3109/0284186X.2010.537693
ReferencesReferences in Scopus
GrantsInstitute of molecular technology for drug discovery and synthesis
DC Field
Value
dc.contributor.authorLum, CT
dc.contributor.authorHuo, L
dc.contributor.authorSun, RWY
dc.contributor.authorLi, M
dc.contributor.authorKung, HF
dc.contributor.authorChe, CM
dc.contributor.authorLin, MCM
dc.date.accessioned2011-07-27T01:27:07Z
dc.date.available2011-07-27T01:27:07Z
dc.date.issued2011
dc.description.abstractBackground. Gold(III) meso-tetraphenylporphyrin (gold-1a) has previously been shown to prolong the survival of hepatocellular carcinoma (HCC)-bearing rats and nasopharyngeal carcinoma (NPC) metastasis-bearing mice. It has also been proved to inhibit the tumor growth of mice bearing NPC, neuroblastoma and colon carcinoma. Mechanistically, gold-1a induces apoptosis, inhibits cell migration and invasion. In this study the efficacies of gold-1a in inhibiting melanoma and angiogenesis were investigated. Material and methods. A mouse melanoma model was used to investigate the efficacy of gold-1a in inhibiting angiogenesis, tumor growth and prolonging the survival of the tumor-bearing animals. The model was established by inoculation of 2 × - 10 5 B16-F1 mouse melanoma cells into the right back flanks of the mice by subcutaneous inoculation. When the tumors grew to 0.2-0.4 cm in diameters, the mice were treated with gold-1a, solvent control or dacarbazine (DTIC) for comparison. Tumor sizes and animal survivals were monitored throughout the experiment. Tumor tissues were collected and immunohistochemically stained with CD31 antibodies for evaluation of intra-tumoral microvessel density (iMVD). Results and conclusion. Gold-1a significantly prolonged the survivals, reduced angiogenesis and tumor growth rates of melanoma-bearing mice. The compound induced necrosis and apoptosis in the mouse melanoma tissues. Gold-1a also downregulated the expression of genes playing roles in angiogenesis. Gold-1a may potentially be used to treat melanoma in patients. © 2011 Informa Healthcare.
dc.description.grantInstitute of molecular technology for drug discovery and synthesis
dc.description.grantcode8708
dc.description.natureLink_to_subscribed_fulltext
dc.identifier.citationActa Oncologica, 2011, v. 50 n. 5, p. 719-726 [How to Cite?]
DOI: http://dx.doi.org/10.3109/0284186X.2010.537693
dc.identifier.doihttp://dx.doi.org/10.3109/0284186X.2010.537693
dc.identifier.epage726
dc.identifier.hkuros187491
dc.identifier.hkuros186306
dc.identifier.isiWOS:000290631600015
Funding AgencyGrant Number
UGCAoE/P-10/01
RGC of the Hong Kong Special Administrative Region, ChinaHKU7705/07M
Funding Information:

This study was supported by grants from the AoE Scheme of UGC (AoE/P-10/01), RGC (HKU7705/07M to MCL) of the Hong Kong Special Administrative Region, China. There are no financial disclosures from any authors.

dc.identifier.issn0284-186X
2011 Impact Factor: 3.33
2011 SCImago Journal Rankings: 0.318
dc.identifier.issue5
dc.identifier.pmid21110776
dc.identifier.scopuseid_2-s2.0-79956150497
dc.identifier.spage719
dc.identifier.urihttp://hdl.handle.net/10722/135044
dc.identifier.volume50
dc.languageeng
dc.publisherInforma Healthcare. The Journal's web site is located at http://www.tandf.co.uk/journals/titles/0284186x.asp
dc.publisher.placeUnited Kingdom
dc.relation.ispartofActa Oncologica
dc.relation.referencesReferences in Scopus
dc.rightsActa Oncologica. Copyright © Informa Healthcare.
dc.subject.meshCarcinoma - drug therapy - mortality
dc.subject.meshMelanoma, Experimental - drug therapy - mortality
dc.subject.meshMetalloporphyrins - pharmacology - therapeutic use
dc.subject.meshNeoplasm Transplantation
dc.subject.meshNeovascularization, Pathologic - prevention and control
dc.titleGold(III) porphyrin 1a prolongs the survival of melanoma-bearing mice and inhibits angiogenesis
dc.typeArticle
Author Affiliations
  1. Institute of Molecular Technology for Drug Discovery and Synthesis, Hong Kong
  2. Chinese University of Hong Kong